Bristol OTC Stock Today

BMYMP -  USA Stock  

USD 1,267  47.00  3.85%

Market Performance
2 of 100
Odds Of Distress
Less than 41
Bristol Myer is selling at 1267.00 as of the 23rd of May 2022; that is 3.85 percent increase since the beginning of the trading day. The stock's last reported lowest price was 1267.0. Bristol Myer has about a 41 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Bristol Myer Squi are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of April 2022 and ending today, the 23rd of May 2022. Click here to learn more.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. The company has 1.64 B outstanding shares of which 10 shares are currently shorted by private and institutional investors with about 0.59 days to cover all short positions. More on Bristol Myer Squi
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Bristol Myer OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Bristol Myer's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bristol Myer or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Bristol Myer Squi has very high historical volatility over the last 90 days
CEO, DirectorLamberto Andreotti  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Bristol Myer's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
Bristol Myer Squi [BMYMP] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Mega-Cap' category with current market capitalization of 2080 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bristol Myer's market, we take the total number of its shares issued and multiply it by Bristol Myer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Bristol Myer Squi classifies itself under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 1.64 B outstanding shares of which 10 shares are currently shorted by private and institutional investors with about 0.59 days to cover all short positions. Bristol Myer Squi has accumulated about 6.07 B in cash with 5.06 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.72.
Check Bristol Myer Probability Of Bankruptcy

Bristol Stock Price Odds Analysis

What are Bristol Myer's target price odds to finish over the current price? Contingent on a normal probability distribution, the odds of Bristol Myer jumping above the current price in 90 days from now is about 23.22%. The Bristol Myer Squi probability density function shows the probability of Bristol Myer otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Bristol Myer Squi has a beta of -0.0237 suggesting as returns on benchmark increase, returns on holding Bristol Myer are expected to decrease at a much lower rate. During the bear market, however, Bristol Myer Squi is likely to outperform the market. Additionally, the company has an alpha of 0.1732, implying that it can generate a 0.17 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 1267.0HorizonTargetOdds Above 1267.0
76.61%90 days
 1,267 
23.22%
Based on a normal probability distribution, the odds of Bristol Myer to move above the current price in 90 days from now is about 23.22 (This Bristol Myer Squi probability density function shows the probability of Bristol OTC Stock to fall within a particular range of prices over 90 days) .

Bristol Myer Squi Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Bristol Myer market risk premium is the additional return an investor will receive from holding Bristol Myer long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bristol Myer. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Bristol Myer's alpha and beta are two of the key measurements used to evaluate Bristol Myer's performance over the market, the standard measures of volatility play an important role as well.

Bristol Stock Against Markets

Picking the right benchmark for Bristol Myer otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bristol Myer otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bristol Myer is critical whether you are bullish or bearish towards Bristol Myer Squi at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bristol Myer without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Alpha Finder Now

   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Module

Bristol Myer Corporate Directors

Bristol Myer corporate directors refer to members of a Bristol Myer board of directors. The board of directors generally takes responsibility for the Bristol Myer's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Bristol Myer's board members must vote for the resolution. The Bristol Myer board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Togo West - Independent DirectorProfile
Karen Vousden - DirectorProfile
Alan Lacy - Independent DirectorProfile
Robert Bertolini - Independent DirectorProfile

Investing Bristol Myer Squi

You need to understand the risk of investing before taking a position in Bristol Myer. The danger of trading Bristol Myer Squi is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bristol Myer is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bristol Myer. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bristol Myer Squi is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Bristol Myer Squi information on this page should be used as a complementary analysis to other Bristol Myer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Bristol OTC Stock analysis

When running Bristol Myer Squi price analysis, check to measure Bristol Myer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myer is operating at the current time. Most of Bristol Myer's value examination focuses on studying past and present price action to predict the probability of Bristol Myer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bristol Myer's price. Additionally, you may evaluate how the addition of Bristol Myer to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Is Bristol Myer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myer. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bristol Myer Squi is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myer's value that differs from its market value or its book value, called intrinsic value, which is Bristol Myer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myer's market value can be influenced by many factors that don't directly affect Bristol Myer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myer's value and its price as these two are different measures arrived at by different means. Investors typically determine Bristol Myer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.